Skip to content

Hand Exercises for Women With Rheumatoid Arthritis and Impaired ADL Ability: an Exploratory Trial

Hand Exercises for Women With Rheumatoid Arthritis and Impaired ADL Ability: an Exploratory Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02140866
Acronym
RAHExercise
Enrollment
55
Registered
2014-05-16
Start date
2014-05-31
Completion date
2016-05-31
Last updated
2017-09-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rheumatoid Arthritis

Brief summary

The study examines whether hand exercise therapy as an add on to a compensatory intervention program focused on joint protection, assistive devices and alternative methods of doing will improve the performance of ADL tasks requiring hand function in patients with rheumatoid arthritis (RA).

Interventions

OTHERCompensatory Intervention Program (CIP)

Sponsors

Oak Foundation
CollaboratorOTHER
Aase and Ejnar Danielsens Foundation
CollaboratorOTHER
Danish Physiotherapy Foundation
CollaboratorUNKNOWN
The Danish Rheumatism Association
CollaboratorOTHER
Danish Association of Occupational Therapist
CollaboratorOTHER
Parker Research Institute
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Female sex. * Age ≥ 18. * Diagnosis of rheumatoid arthritis (2). * Involvement of the hands, due to minimum one tender wrist, metacarpophalangeal (MCP) or proximal interphalangeal (PIP) joint in one of the hands. * Be on stable medication for at least 3 months prior to participation. * Self-reported decreased ability to perform personal and instrumental ADL tasks involving the hands.

Exclusion criteria

* Significant osteoarthritis of the hand assessed at the initial examination by the rheumatologist * Hand surgery within 6 months of study participation * Other pain condition involving muscles and/or joints, e.g. fibromyalgia. * Prednisolon therapy, change in dose of biological agent or start of treatment with a new biological agent within the last 3 month before study start. * Inability to understand the information or to speak Danish * Any other condition that in the opinion of the investigator or accessing rheumatologist puts an otherwise eligible participant at increased risk by participation or otherwise make the person unfit for participation.

Design outcomes

Primary

MeasureTime frame
The Assessment of Motor and Process Skills (AMPS) - the motor skill scalewithin 2 weeks post intervention

Secondary

MeasureTime frame
The Assessment of Motor and Process Skills(AMPS) - the process skill scalewithin 2 weeks post intervention
The Activities of Daily Living Questionnaire (ADL-Q)within 2 weeks post intervention
Overall disease activity (DAS-28)within 2 weeks post intervention
Grip strengthwithin 2 weeks post intervention
Health Assessment Questionnaire (HAQ)within 2 weeks post intervention

Other

MeasureTime frame
Ultrasound Dopplerwithin 2 weeks post intervention

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 21, 2026